Schedule 13G ownership disclosure

NEOS THERAPEUTICS INC

Security class unavailable · CUSIP: 64052L106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
337,247
Percent of class
0.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-21-000107
Form type
SC 13G/A
Filer
GOLDMAN SACHS & CO. LLC
CIK
CIK 769993
Filed
Feb 12, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub